Phosphodiesterase 4 inhibitors for the treatment of COPD
- Author
- STURTON, Graham1 ; FITZGERALD, Mary1
[1] Bayer plc. Pharma Research, Berkshire, United Kingdom - Conference title
- COPD symposium: into the new millennium
- Conference name
- COPD Symposium (Lund 2001-04)
- Author (monograph)
- AstraZeneca, International (Funder/Sponsor)
- Source
Chest. 2002, Vol 121, Num 5, pp 192S-196S ; ref : 23 ref
- CODEN
- CHETBF
- ISSN
- 0012-3692
- Scientific domain
- Anesthesia, intensive care; Cardiology, blood circulation, phlebology; Pneumology
- Publisher
- American College of Chest Physicians, Northbrook, IL
- Publication country
- United States
- Document type
- Conference Paper
- Language
- English
- Keyword (fr)
- Animal Antiinflammatoire Asthme Bronchopneumopathie obstructive Chimiothérapie Chronique Cilomilast Inhibiteur enzyme Phosphodiesterase I Pronostic Roflumilast Traitement BAY 19-8004 Appareil respiratoire pathologie Bronche pathologie Enzyme Esterases Hydrolases Phosphoric diester hydrolases Poumon pathologie
- Keyword (en)
- Animal Antiinflammatory agent Asthma Obstructive pulmonary disease Chemotherapy Chronic Cilomilast Enzyme inhibitor Phosphodiesterase I Prognosis Roflumilast Treatment Respiratory disease Bronchus disease Enzyme Esterases Hydrolases Phosphoric diester hydrolases Lung disease
- Keyword (es)
- Animal Antiinflamatorio Asma Broncopneumopatía obstructiva Quimioterapia Crónico Cilomilast Inhibidor enzima Phosphodiesterase I Pronóstico Roflumilast Tratamiento Aparato respiratorio patología Bronquio patología Enzima Esterases Hydrolases Phosphoric diester hydrolases Pulmón patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02D Respiratory system
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 13679117
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1378/chest.121.5_suppl.192S 
https://dx.doi.org/10.1378/chest.121.5_suppl.192S
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:30:\"10.1378\/chest.121.5_suppl.192S\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:56:\"Phosphodiesterase 4 inhibitors for the treatment of COPD\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Chest\";s:9:\"\u0000*\u0000stitle\";s:5:\"Chest\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"121\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"192S\";s:8:\"\u0000*\u0000epage\";s:4:\"196S\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-3692\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"STURTON\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Graham\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:16:\"FITZGERALD, Mary\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CHETBF\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:39:\"COPD symposium: into the new millennium\";s:8:\"\u0000*\u0000title\";s:56:\"Phosphodiesterase 4 inhibitors for the treatment of COPD\";s:8:\"\u0000*\u0000place\";s:14:\"Northbrook, IL\";s:6:\"\u0000*\u0000pub\";s:36:\"American College of Chest Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:30:\"10.1378\/chest.121.5_suppl.192S\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:56:\"Phosphodiesterase 4 inhibitors for the treatment of COPD\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Chest\";s:9:\"\u0000*\u0000stitle\";s:5:\"Chest\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"121\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"192S\";s:8:\"\u0000*\u0000epage\";s:4:\"196S\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-3692\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"STURTON\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Graham\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:16:\"FITZGERALD, Mary\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CHETBF\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:39:\"COPD symposium: into the new millennium\";s:8:\"\u0000*\u0000title\";s:56:\"Phosphodiesterase 4 inhibitors for the treatment of COPD\";s:8:\"\u0000*\u0000place\";s:14:\"Northbrook, IL\";s:6:\"\u0000*\u0000pub\";s:36:\"American College of Chest Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:30:\"10.1378\/chest.121.5_suppl.192S\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:30:\"10.1378\/chest.121.5_suppl.192S\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:56:\"Phosphodiesterase 4 inhibitors for the treatment of COPD\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Chest\";s:9:\"\u0000*\u0000stitle\";s:5:\"Chest\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"121\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"192S\";s:8:\"\u0000*\u0000epage\";s:4:\"196S\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-3692\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"STURTON\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Graham\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:16:\"FITZGERALD, Mary\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CHETBF\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:39:\"COPD symposium: into the new millennium\";s:8:\"\u0000*\u0000title\";s:56:\"Phosphodiesterase 4 inhibitors for the treatment of COPD\";s:8:\"\u0000*\u0000place\";s:14:\"Northbrook, IL\";s:6:\"\u0000*\u0000pub\";s:36:\"American College of Chest Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:30:\"10.1378\/chest.121.5_suppl.192S\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:56:\"Phosphodiesterase 4 inhibitors for the treatment of COPD\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Chest\";s:9:\"\u0000*\u0000stitle\";s:5:\"Chest\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"121\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"192S\";s:8:\"\u0000*\u0000epage\";s:4:\"196S\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-3692\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"STURTON\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Graham\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:16:\"FITZGERALD, Mary\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CHETBF\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:39:\"COPD symposium: into the new millennium\";s:8:\"\u0000*\u0000title\";s:56:\"Phosphodiesterase 4 inhibitors for the treatment of COPD\";s:8:\"\u0000*\u0000place\";s:14:\"Northbrook, IL\";s:6:\"\u0000*\u0000pub\";s:36:\"American College of Chest Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:30:\"10.1378\/chest.121.5_suppl.192S\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:56:\"Phosphodiesterase 4 inhibitors for the treatment of COPD\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Chest\";s:9:\"\u0000*\u0000stitle\";s:5:\"Chest\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"121\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"192S\";s:8:\"\u0000*\u0000epage\";s:4:\"196S\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-3692\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"STURTON\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Graham\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:16:\"FITZGERALD, Mary\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CHETBF\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:39:\"COPD symposium: into the new millennium\";s:8:\"\u0000*\u0000title\";s:56:\"Phosphodiesterase 4 inhibitors for the treatment of COPD\";s:8:\"\u0000*\u0000place\";s:14:\"Northbrook, IL\";s:6:\"\u0000*\u0000pub\";s:36:\"American College of Chest Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
